Advertisement

Topics

Epoch Pharmaceuticals Company Profile

02:07 EDT 24th October 2017 | BioPortfolio

Epoch Biosciences is a biotechnology company making products to help scientists around the world who perform genetic research to improve our lives and our environment. The Company's technologies facilitate rapid, accurate and cost-effective genetic analysis at the scale necessary to generate the massive amounts of genetic information being studied today.

Epoch Biosciences' technologies are useful in genetic research, diagnostics, drug development, infectious disease detection, prenatal testing and population screening to assess our risk of disease or to predict our response to drugs. Pioneering companies including Applied Biosystems, Third Wave Technologies and Incyte Genomics use Epoch Biosciences' technology to help in these efforts. The company also markets its own products and systems directly to users. In 2001, Epoch Biosciences introduced the MGB Eclipse™ Probe System for use by academic, medical and biopharmaceutical industry researchers. Epoch's scientific and management teams are committed to providing a continuing stream of innovations that provide an edge to people working at the forefront of discovery.

Location

21720 - 23rd Drive SE number 150
Bothell
Washington
98021
United States of America

Contact

Phone: 425 482 5555
Fax: 425 482 5550
Email: investorinfo@epochbio.com


News Articles [474 Associated News Articles listed on BioPortfolio]

Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing

SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore...

Myriad Genetics Launches riskScore Beginning The Next Epoch In Hereditary Cancer Testing

  Life Sciences Jobs   ...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Rising seas could be detrimental to human health on a much shorter time scale, say researchers

In 2014, a team of researchers led by a paleobiologist from the University of Missouri found that clams from the Holocene Epoch (that began 11,700 years ago) contained clues about how sea level rise d...

Putting down the scalpel: The aging surgeon

In the early epoch of human development, mankind learned to shape and sharpen wood, stone and metal objects to facilitate plunging them deep into other humans’ chests, abdomens, skulls and eyes in t...

New infant cranium from the African Miocene sheds light on ape evolution

The evolutionary history of extant hominoids (humans and apes) remains poorly understood. The African fossil record during the crucial time period, the Miocene epoch, largely comprises isolated jaws a...

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has receiv...

Drugs and Medications [274 Associated Drugs and Medications listed on BioPortfolio]

Epoch [NSE Products, Inc.]

Epoch Acne Medication Blemish Treatment

Nu skin epoch [Alberto-Culver USA Inc.]

Epoch Antiseptic Hand Sanitizer

Epoch [NSE Products, Inc.]

Epoch® Antiseptic Hand Sanitizer

Epoch [NSE Products, Inc.]

epoch Ava puhi moni Anti-Dandruff Shampoo

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

PubMed Articles [143 Associated PubMed Articles listed on BioPortfolio]

Neural correlates of serial order effect in verbal divergent thinking.

During the course of divergent thinking (DT), the number of generated ideas decreases while the originality of ideas increases. This phenomenon is labeled as serial order effect in DT. The present stu...

Survival and Neurodevelopmental Outcomes among Periviable Infants.

Background Data reported during the past 5 years indicate that rates of survival have increased among infants born at the borderline of viability, but less is known about how increased rates of surviv...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Clinical Trials [243 Associated Clinical Trials listed on BioPortfolio]

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

This research study is evaluating the combination of a study drug, venetoclax, and a standard chemotherapy regimen, EPOCH-R, as a possible treatment for Richter's Syndrome. The drugs invo...

R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL

Patients initially are randomized into 4 arms: Arm I: R-DA-EPOCH; Arm II: R-DA-EPOCH + auto-SCT; Arm III: R-CEOP90; Arm IV: R-CEOP90 + auto-SCT. Patients who achieved complete remi...

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Purpose: to evaluate an efficacy of chemotherapy regimens R-DA-EPOCH-21 and R-mNHL-BFM-90 with and without autologous hematopoietic stem cells transplantation (auto-SCT) in newly diagnosed...

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

This is a randomized study of combination chemotherapy (EPOCH II) versus EPOCH II and immunotherapy with peripheral blood stem cells (PBSC) and IL-2 in patients with relapsed Hodgkin's and...

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

The prognosis of AIDS-related Non-Hodgkin's lymphoma is poor, especially in the relapsed setting. There is no standard treatment, and the few small studies that have been conducted have r...

Companies [1289 Associated Companies listed on BioPortfolio]

Epoch Pharmaceuticals

Epoch Biosciences is a biotechnology company making products to help scientists around the world who perform genetic research to improve our lives and our environment. The Company's technologies facil...

EPOCH Senior Living

EPOCH Senior Living is a regional provider of senior living options, offering independent and assisted living, skilled nursing and rehabilitation, and memory care. EPOCH Senior Li...

Epoch Biosciences Incorporated

Epoch Biosciences is a biotechnology company making products to help scientists around the world who perform genetic research to improve our lives and our environment. The Company's technologies facil...

Epoch Biosciences

Epoch Biosciences is a biotechnology company that makes products and develops technologies to help scientists, clinicians, and physicians around the world perform genetic research to improve our lives...

Integral Systems, Inc

Founded in 1982, Integral Systems (NASDAQ:ISYS) builds satellite ground systems for command and control, integration and test, data processing, and simulation. The company has provided ground systems ...

More Information about "Epoch Pharmaceuticals" on BioPortfolio

We have published hundreds of Epoch Pharmaceuticals news stories on BioPortfolio along with dozens of Epoch Pharmaceuticals Clinical Trials and PubMed Articles about Epoch Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epoch Pharmaceuticals Companies in our database. You can also find out about relevant Epoch Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record